mHealth for Phosphorus Management in CKD. — PHOSFO_OK  

Dialysis Related Complication Clinical Trial

Official title: mHealth System for the Self-control of Hyperphosphatemia in Patients With CKD.

Status Active, not recruiting

Clinical Trial Summary

The project aims to generate an mHealth environment in which CKD patients are empowered in terms of the self-management of their hyperphosphatemia pathology, while under medical supervision. Such environment will allow nephrologists to inform patients beyond their traditional point-of-care and will allow patients to provide feedback on their condition in a timely manner that benefits the CKD collective. In this way we delve in a technological area that has been argued that remains underutilized within nephrology (1) and that should be perceived as an opportunity for CKD (2). In our work, we will build from recent related efforts in the control of hyperphosphatemia (3).

Clinical Trial Description

The working hypotheses are listed as follows: 1. Hyperphosphatemia is an important problem in the CKD realm, but difficult to manage because patients are often not aware of its importance. In addition, current clinical practice does not allow nephrologists to evaluate the patient's real understanding of their recommendations. 2. The patient could benefit from a smartphone-based interactive virtual assistant tool: an integrated personalized management system to achieve a form of participatory, personalized, predictive and preventive medicine in the specific domain of a pathology associated to CKD. 3. The combination of a flexible information channel with an interactive data visualization tool on mobile devices can be a most intuitive way to communicate with the patient, particularly if it allows comparison with other patients in similar situation. Additionally, data visualization can assist nephrologists in the clinical management of patients. Primary Objective: 1-Analysis of the superiority of a Medical Mobile Application for Patient Support to educate CKD patients on how to self-manage their phosphate levels versus standard of care in lowering serum phosphorus by assessing changes in serum phosphorus comparing baseline with 6-months follow-up. Secondary Objectives: 1. Adherence to treatment with phosphate binders. 2. Impact in Quality of Life of patients with CKD. 3. Satisfaction of such a tool. ;

Related Conditions & MeSH terms

• Dialysis Related Complication
• Hyperphosphatemia

• NCT number: NCT05389826
• Study type: Interventional
• Source: Hospital Universitari de Bellvitge
• Status: Active, not recruiting
• Phase: N/A
• Start date: June 1, 2022
• Completion date: October 15, 2023